A carregar...
A Case of Isolated Adrenocorticotropic Hormone Deficiency Caused by Pembrolizumab
Pembrolizumab (Keytruda®) is an anti-programmed cell death 1-specific monoclonal antibody that has become the standard second-line chemotherapy for unresectable advanced microsatellite instability-high colorectal cancer. Several immune-related adverse events (irAEs), particularly endocrinopathy, are...
Na minha lista:
| Publicado no: | Case Rep Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7154275/ https://ncbi.nlm.nih.gov/pubmed/32308578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000505687 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|